Lower Respiratory (1&2) Review

12345678910111213141516171819202122232425262728293031323334353637383940414243
Across
  1. 2. TB drug that inhibits mycolic acid synthesis and is contraindicated with liver disease
  2. 3. collection of purulent fluid within pleural space
  3. 8. common cause of pneumonia in infants and young children
  4. 9. highly contagious respiratory infection, covered by Tdap vaccine
  5. 13. most common drug used for inflammation treatment
  6. 14. TB is caused by the mycobacterium _______ microorganism
  7. 15. strongly urge patients to avoid this while on all TB drug regimen
  8. 18. lesion found in lungs, hallmark of primary TB infection
  9. 19. type of pleural effusion r/t non-inflammatory conditions
  10. 21. antiseptic commonly used for oral cares, may stain teeth
  11. 26. most common bodily response to any infection or injury
  12. 31. these alveolar pores become occluded or plugged
  13. 32. best prevention for whooping cough
  14. 34. type of culture that is gold standard for TB diagnosis
  15. 36. bloody cough
  16. 37. most common lung cancer
  17. 39. mnemonic for standard TB drug therapy
  18. 40. chemical _____ can be done with talc powder to obliterate pleural space
  19. 41. most common inhaled bronchodilator medication
  20. 42. cause of 80-90% of lung cancer cases
  21. 43. collapsed, air-less alveoli
Down
  1. 1. type of hernia that requires prompt recognition and intervention
  2. 4. type of TB skin test
  3. 5. pleural lining inflammation
  4. 6. inflammation/congestion of bronchioles, commonly associated with RSV
  5. 7. one cause of pneumonia
  6. 9. common cause of hospital-acquired and ventilator-associated pneumonias
  7. 10. MAB that targets vascular endothelial growth factor; monitor for bleeding and GI perforation with this drug
  8. 11. best time of day to collect sputum samples
  9. 12. irreversible problem of interstitial lung disease
  10. 16. type of O2 that is helpful with respiratory conditions
  11. 17. type of isolation required for RSV
  12. 20. MAB that targets PD-1 for NSCLC
  13. 22. inflammation of bronchi
  14. 23. commonly used immunosuppressant after lung transplant, utilizes CYP450, must monitor drug levels and kidney function
  15. 24. TB drug that is strong CYP450 inducer, turns body fluids orange
  16. 25. used for diagnosis (biopsy) and for therapeutic purposes (lavage/suction))
  17. 27. leading cause of cancer-related deaths in US
  18. 28. AKA hospital-acquired pneumonia
  19. 29. juice to avoid if taking medications that utilize CYP450 enzyme for metabolism
  20. 30. abdomen shape that is a red flag at birth especially when associated with respiratory distress
  21. 33. type of classification system used for staging cancers
  22. 34. type of lung cancer that has very rapid growth and poor prognosis
  23. 35. possible treatment option for end-stage lung disease
  24. 38. type of pleural effusion r/t inflammatory conditions
  25. 40. acute infection of lung parenchyma